Dr Reddy's Labs plans to roll out cheaper Wegovy copycat across 87 countries in 2026: CEO Ruchika Sharma25 July 2025 4:30 PM ISTHyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an affordable copycat version...
Post WHO alert, Novo Nordisk seeks EMA nod for higher dose of obesity treatment Wegovy Ruchika Sharma9 July 2025 11:36 AM ISTDenmark: Following a recent World Health Organization (WHO) alert on semaglutide-containing medicines, Novo Nordisk has announced the...
Weight loss drug: Novo Nordisk Wegovy now available in India Ruchika Sharma25 Jun 2025 3:52 PM ISTMumbai: Novo Nordisk, a global healthcare company headquartered in Denmark, has announced the launch of Wegovy (injectable Semaglutide)...
Delhi HC Restrains Dr Reddy's from Selling Semaglutide Drug in India Amid Novo Nordisk Row Ruchika Sharma31 May 2025 6:19 PM ISTNovo Nordisk has accused Dr Reddy's and OneSource of importing semaglutide API and using it to make and export formulations.
Lars Fruergaard Jorgensen to step down as CEO of Novo Nordisk Ruchika Sharma18 May 2025 10:45 AM ISTDenmark: Novo Nordisk has announced that Lars Fruergaard Jorgensen will step down from his role as CEO of Novo Nordisk. He will continue as CEO...
Novo Nordisk application for oral Wegovy accepted by USFDA for weight loss Ruchika Sharma3 May 2025 3:21 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submission for an...
Novo Nordisk promotes Rishang Deoras to Global Director - Diabetes Commercial Unit Ruchika Sharma17 April 2025 5:30 PM ISTNovo Nordisk has promoted Rishang Deoras to Global Director - Diabetes Commercial Unit.Deoras shared the news in a LinkedIn post,...
Novo Nordisk reshapes Executive management team Ruchika Sharma4 April 2025 11:30 AM IST Novo Nordisk HA has announced that Camilla Sylvest has decided to leave the company after a distinguished career of 28 years with the Company,...
Novo Nordisk, The United Bio-Technology ink pact for 'triple G' obesity drug Ruchika Sharma25 March 2025 3:30 PM ISTChina: Novo Nordisk and The United Laboratories International Holdings Limited (TUL)'s wholly-owned subsidiary The United Bio-Technology...
Novo Nordisk regains membership in UK pharma body Ruchika Sharma18 March 2025 3:30 PM ISTLondon: Danish pharmaceutical giant Novo Nordisk has regained its membership in the UK's pharmaceutical industry body after serving a two-year...
CagriSema demonstrates superior weight loss in adults with obesity, type 2 diabetes in REDEFINE 2 trial: Novo Nordisk Ruchika Sharma14 March 2025 2:00 PM ISTDenmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial, Novo...
Novo Nordisk Ozempic get USFDA nod for reduction of kidney disease worsening risk, cardiovascular death in adults with type 2 diabetes, chronic kidney disease Ruchika Sharma29 Jan 2025 1:30 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease...
